Clinical trial
S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic…
NCT00003369 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00003369 |
|---|---|
| Title | S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer |
| Official title | Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, tirapazamine |
| Enrollment | 56 |
| Start date | Aug 1, 1998 |
| Primary completion | Oct 1, 2003 |
| Completion | Jul 1, 2004 |
| First posted | Jun 24, 2004 |
| Last update posted | Jun 14, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: